Iclepertin Once Daily Over 26 Week Treatment Period for schizophrenia
This study is completed in the United States, in the United Kingdom, in Belgium, .... It is testing Iclepertin Once Daily Over 26 Week Treatment Period for schizophrenia.
SchizophreniaDrugFrom 18 Years to 50 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Iclepertin Once Daily Over 26 Week Treatment Period may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Iclepertin Once Daily Over 26 Week Treatment Period, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Argentina, in Austria, and in Belgium.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: August 9, 2021
Recruitment status
Completed
Enrollment listed in the registry
609
Sponsor
Boehringer Ingelheim
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, United Kingdom, Belgium, ...
Age range
From 18 Years to 50 Years
Official registry ID
NCT04860830
Official title
A Phase III Randomized, Double-blind, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Iclepertin Once Daily Over 26 Week Treatment Period in Patients With Schizophrenia (CONNEX-3)
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT04860830. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Argentina · 9 sites
Clínica Privada Banfield
Banfield
Site status: Not listed — confirm with the team
Fundación para el Estudio y Tratamiento de las Enfermedades Mentales (FETEM)
CABA
Site status: Not listed — confirm with the team
Fundación FunDaMos para la asistencia e investigación en psiquiatría
CABA
Site status: Not listed — confirm with the team
CEN (Centro Especializado Neurociencias)
Córdoba
Site status: Not listed — confirm with the team
Instituto Modelo de Neurología Lennox
Córdoba
Site status: Not listed — confirm with the team
Instituto Médico DAMIC S.R.L.
Córdoba
Site status: Not listed — confirm with the team
Instituto de Neurociencias San Agustín
La Plata
Site status: Not listed — confirm with the team
Instituto Médico de la Fundación Estudios Clínicos
Rosario
Site status: Not listed — confirm with the team
Centro Medico Luquez
San Vicente
Site status: Not listed — confirm with the team
Austria · 1 site
AKH - Medical University of Vienna
Vienna
Site status: Not listed — confirm with the team
Belgium · 4 sites
CUP Vivalia -La Clairière
Bertix
Site status: Not listed — confirm with the team
Sint-Kamillus
Bierbeek
Site status: Not listed — confirm with the team
Universitair Psychiatrisch Centrum Duffel (UPC Duffel)
Duffel
Site status: Not listed — confirm with the team
Meclinas
Mechelen
Site status: Not listed — confirm with the team
Brazil · 2 sites
Ruschel Medicina e Pesquisa Clínica
Rio de Janeiro
Site status: Not listed — confirm with the team
Clínica Viver - Centro de Desospitalização Humana
São Paulo
Site status: Not listed — confirm with the team
Bulgaria · 3 sites
Filipopolis Ambulatory for Group Practice for Specialized Care in Psychiatry
Plovdiv
Site status: Not listed — confirm with the team
Medical Center "Spectar"
Plovdiv
Site status: Not listed — confirm with the team
Medical Center Hera EOOD
Sofia
Site status: Not listed — confirm with the team
China · 11 sites
Beijing Anding Hospital
Beijing
Site status: Not listed — confirm with the team
The Second Xiangya Hospital Of Central South University
Changsha
Site status: Not listed — confirm with the team
The third affiliated hospital of Sun Yat-Sen University
Guangzhou
Site status: Not listed — confirm with the team
Huzhou Third Municipal Hospital
Huzhou
Site status: Not listed — confirm with the team
Nanjing Brain Hospital
Nanjing
Site status: Not listed — confirm with the team
Shenzhen Kangning Hospital
Shenzhen
Site status: Not listed — confirm with the team
The First Hospital of Hebei Medical University
Shijiazhuang
Site status: Not listed — confirm with the team
Tianjin Anding Hospital
Tianjin
Site status: Not listed — confirm with the team
First Affiliated Hospital of Xi'an JiaoTong University
Xi'an
Site status: Not listed — confirm with the team
Xi'an Mental Health Center
Xi'an
Site status: Not listed — confirm with the team
Zhumadian Psychiatric Hospital
Zhumadian
Site status: Not listed — confirm with the team
Czechia · 6 sites
National Institute of Mental Health
Klecany
Site status: Not listed — confirm with the team
MP Meditrine s.r.o.
Ostrava
Site status: Not listed — confirm with the team
A-SHINE s.r.o
Pilsen
Site status: Not listed — confirm with the team
PRAGTIS s.r.o.
Prague
Site status: Not listed — confirm with the team
INEP medical s.r.o.
Prague
Site status: Not listed — confirm with the team
Psychiatrie Ricany s.r.o.
Říčany
Site status: Not listed — confirm with the team
Denmark · 3 sites
Aalborg Universitetsshospital
Aalborg
Site status: Not listed — confirm with the team
Aarhus University Hospital
Aarhus
Site status: Not listed — confirm with the team
Psykiatrisk Center Glostrup
Glostrup Municipality
Site status: Not listed — confirm with the team
Finland · 3 sites
HUS Jorvi Hospital
Espoo
Site status: Not listed — confirm with the team
Aurora hospital
Helsinki
Site status: Not listed — confirm with the team
CRST - Clinical Research Services Turku
Turku
Site status: Not listed — confirm with the team
Germany · 5 sites
Studienzentrum für Neurologie und Psychiatrie
Böblingen
Site status: Not listed — confirm with the team
LWL-Klinik Dortmund
Dortmund
Site status: Not listed — confirm with the team
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz
Site status: Not listed — confirm with the team
Klinikum der Universität München - Campus Innenstadt
München
Site status: Not listed — confirm with the team
Universitätsklinikum Tübingen
Tübingen
Site status: Not listed — confirm with the team
Lithuania · 4 sites
JSC Romuvos Clinic
Kaunas
Site status: Not listed — confirm with the team
LUHS KH Psichiatric Clinic Mariu Division
Kaunas
Site status: Not listed — confirm with the team
JSC Medical center "Puriena"
Šilutė
Site status: Not listed — confirm with the team
Vilnius City Mental Health Center
Vilnius
Site status: Not listed — confirm with the team
Mexico · 7 sites
Centro de Investigacion Integral MEDIVEST S.C
Chihuahua City
Site status: Not listed — confirm with the team
Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada S.C.
Culiacán
Site status: Not listed — confirm with the team
Hospital Aranda de la Parra
León
Site status: Not listed — confirm with the team
Centro de Investigación Clinica Acelerada, S.C.
Mexico City
Site status: Not listed — confirm with the team
Iecsi S.C.
Monterrey
Site status: Not listed — confirm with the team
Hospital Universitario Dr Jose Eleuterio Gonzalez
Monterrey
Site status: Not listed — confirm with the team
BIND Investigaciones S.C.
San Luis Potosí City
Site status: Not listed — confirm with the team
Portugal · 3 sites
ULS da Região de Leiria, E.P.E.
Leiria
Site status: Not listed — confirm with the team
ULS de Santa Maria, E.P.E
Lisbon
Site status: Not listed — confirm with the team
ULS de Loures-Odivelas, E.P.E
Loures
Site status: Not listed — confirm with the team
Serbia · 3 sites
Clinical Hospital Center Dr. Dragisa Misovic
Belgrade
Site status: Not listed — confirm with the team
General Hospital Euromedik
Belgrade
Site status: Not listed — confirm with the team
Special Hospital for Psychiatric Diseases Gornja Toponica
Gornja Toponica
Site status: Not listed — confirm with the team
South Korea · 6 sites
Inje University Busan Paik Hospital
Busan
Site status: Not listed — confirm with the team
Yeungnam University Medical Center
Daegu
Site status: Not listed — confirm with the team
Chonnam National University Hospital
Gwangju
Site status: Not listed — confirm with the team
Seoul National University Bundang Hospital
Seongnam
Site status: Not listed — confirm with the team
CHA Bundang Medical Center
Seongnam-si
Site status: Not listed — confirm with the team
Pusan National University Yangsan Hospital
Yangsan
Site status: Not listed — confirm with the team
Taiwan · 8 sites
Kai-Syuan Psychiatric Hospital
Kaohsiung City
Site status: Not listed — confirm with the team
Chang Gung Memorial Hospital-Keelung
Keelung
Site status: Not listed — confirm with the team
Chung Shan Medical University Hospital
Taichung
Site status: Not listed — confirm with the team
NCKUH
Tainan
Site status: Not listed — confirm with the team
National Taiwan University Hospital
Taipei
Site status: Not listed — confirm with the team
Taipei Veterans General Hospital
Taipei
Site status: Not listed — confirm with the team
Taoyuan Psychiatric Center
Taoyuan
Site status: Not listed — confirm with the team
Chang Gung Memorial Hospital, Linkou
Taoyuan County
Site status: Not listed — confirm with the team
United Kingdom · 8 sites
Bodmin Community Hospital
Bodmin
Site status: Not listed — confirm with the team
The Fritchie Centre
Cheltenham
Site status: Not listed — confirm with the team
Redesmere
Chester
Site status: Not listed — confirm with the team
Western General Hospital
Edinburgh
Site status: Not listed — confirm with the team
Queen Elizabeth University Hospital
Glasgow
Site status: Not listed — confirm with the team
Maudsley Hospital
London
Site status: Not listed — confirm with the team
Warneford Hospital
Oxford
Site status: Not listed — confirm with the team
Moorgreen Hospital
Southampton
Site status: Not listed — confirm with the team
United States · 24 sites
Advanced Research Center, Inc.
Anaheim, California
Site status: Not listed — confirm with the team
ProScience Research Group
Culver City, California
Site status: Not listed — confirm with the team
University of California Los Angeles
Los Angeles, California
Site status: Not listed — confirm with the team
CNRI - Los Angeles
Pico Rivera, California
Site status: Not listed — confirm with the team
Stanford University Medical Center
Stanford, California
Site status: Not listed — confirm with the team
Sunwise Clinical Research-Walnut Creek-70166
Walnut Creek, California
Site status: Not listed — confirm with the team
Advanced Medical Research Group Inc
Hollywood, Florida
Site status: Not listed — confirm with the team
Accel Research Sites Network
Maitland, Florida
Site status: Not listed — confirm with the team
University of Miami
Miami, Florida
Site status: Not listed — confirm with the team
Ivetmar Medical Group, LLC
Miami, Florida
Site status: Not listed — confirm with the team
Nova Psychiatry Inc.
Orlando, Florida
Site status: Not listed — confirm with the team
Synexus Clinical Research-Atlanta-67262
Atlanta, Georgia
Site status: Not listed — confirm with the team
Augusta University
Augusta, Georgia
Site status: Not listed — confirm with the team
Center for Behavioral Health, LLC
Gaithersburg, Maryland
Site status: Not listed — confirm with the team
Arch Clinical Trials, LLC
St Louis, Missouri
Site status: Not listed — confirm with the team
Omaha Insomnia and Psychiatric Services
Omaha, Nebraska
Site status: Not listed — confirm with the team
Hassman Research Institute-Berlin-60540
Berlin, New Jersey
Site status: Not listed — confirm with the team
UNC Center for Excellence in Community Mental Health, North Carolina Psychiatric Research Center
Raleigh, North Carolina
Site status: Not listed — confirm with the team
Midwest Clinical Research
Dayton, Ohio
Site status: Not listed — confirm with the team
Rivus Wellness and Research Institute
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Cutting Edge Research Group
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Oasis Life Care
State College, Pennsylvania
Site status: Not listed — confirm with the team
Ben Taub General Hospital
Houston, Texas
Site status: Not listed — confirm with the team
LinQ Research, LLC-Richmond-70076
Richmond, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Iclepertin, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 50 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Boehringer Ingelheim, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
